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Abstract
Aim: The study identiﬁes the relevant obstetric factors associated with fetal heart rate (FHR) monitoring for
cerebral palsy (CP) in pregnant women with hypertensive disorders of pregnancy (HDP).
Methods: The subjects were neonates with CP (birth weight ≥ 2000 g, gestational age ≥ 33 weeks) who were
approved for compensation for CP by the Operating Organization of the Japan Obstetric Compensation Sys-
tem between 2009 and 2012. After selection of women with antepartum HDP, obstetric characteristics associ-
ated with FHR monitoring were analyzed.
Results: The subjects included 33 neonates with CP whose mothers suffered from HDP during pregnancy
and 450 neonates whose mothers did not develop HDP. The rates of placental abruption (48.5% vs. 20%;
P < 0.001) and light-for-gestational age (12.1% vs. 2.2%; P = 0.011) were signiﬁcantly higher in women with
HDP than in those without HDP. Regarding FHR pattern analysis, fetal bradycardia was observed on
admission to hospital in 94% of women with placental abruption. In women without placental abruption,
FHR was likely to indicate a favorable pattern on admission, but became worse with the progression of
labor.
Conclusion: This is ﬁrst study to clinically demonstrate FHR patterns in CP cases in association with HDP.
Although antepartum CP is undetectable, pregnant women with HDP should be placed under strict observa-
tion and management to minimize fetal hypoxic conditions during labor.
Key words: cerebral palsy, fetal heart rate, hypertension, hypertensive disorder of pregnancy, hypoxia, pla-
cental abruption.
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Introduction
Cerebral palsy (CP) is a physical disability that occurs
in children. CP is associated with neonatal hypoxia
and acidemia involved with non-reassuring fetal sta-
tus during labor as a result of placental and umbilical
cord abnormalities (placental abruption and umbilical
cord prolapse).1
The pathophysiology of hypertensive disorders of
pregnancy (HDP) is complex and involves multiple
organ systems. In this disorder, increasing resistance
of maternal systemic blood vessels adversely affect
blood ﬂow, not only in maternal organ systems, but
also the placenta, resulting in both maternal and neo-
natal pathologic conditions.2–4 Therefore, identifying
the clinical course and obstetric factors of CP associ-
ated with HDP could be important for making recom-
mendations for the management of HDP and
reducing the rate of CP.
The present study aimed to identify the relevant
obstetric factors associated with fetal heart rate (FHR)
pattern for CP in pregnant women with HDP.
Methods
The details of the Japan Obstetric Compensation Sys-
tem for Cerebral Palsy (JOCSC) have been described
in our previous report. 1 The JOCSC was launched in
January 2009 to provide prompt no-fault compensa-
tion for children diagnosed with severe CP associated
with obstetric factors and for their respective families.
The JOCSC also provides information that could help
in prevention, early resolution of disputes and
improvement in the quality of obstetric health care.
A case review for compensation is performed by a
review committee. After a child is declared eligible to
receive compensation by this review committee, the
causes for CP are analyzed individually by the Causal
Analysis Committee, which consists of obstetricians,
pediatricians, midwives and lawyers. Once collected,
the Recurrence Prevention Committee analyzes these
individual cases from an epidemiological standpoint.
The subjects of the current study were neonates with
CP who were approved for compensation by a review
of the Operating Organization of JOCSC.
All procedures performed in the study involving
human participants were in accordance with the ethi-
cal standards of the institutional and/or national
research committee and with the 1964 Helsinki decla-
ration and its later amendments or comparable ethical
standards. The Institutional Review Boards of the
JOCSC approved the study. Written informed consent
was not obtained from the patients; however, they
were provided with a supplemental ﬁle announcing
the implementation of a ‘case-control study of cerebral
palsy and prevention of its recurrence’. Although the
analysis was retrospective, data from the anonymized
JOCSC database were collected in a normal clinical set-
ting and the conﬁdentiality of the patients involved
was protected. All patient records/information was
de-identiﬁed prior to analysis.
Criteria for inclusion in the present study were as
follows: neonates born between January 2009 and
December 2012; with a birth weight of ≥ 2000 g, and
gestational age ≥ 33 weeks; and with severe disability
resulting from CP independent of congenital causes or
factors during the neonatal period or later, with dis-
ability certiﬁed to be of ﬁrst or second-degree severity
according to the grade of disability deﬁnitions in the
Welfare of Physically Disabled Persons Act.
After selection of the neonates of mothers with
antepartum HDP, obstetric clinical characteristics
associated with FHR pattern and disease course were
analyzed. Cases were subcategorized into groups
with and without placental abruption and the FHR
record was retrospectively analyzed for each group.
We categorized cases into ﬁve different groups
based on the FHR pattern at admission for labor and
just before delivery according to Phelan et al.5 The
bradycardia group comprised fetuses with bradycar-
dia or persistent severe decelerations with loss of vari-
ability at admission for labor and no recovery until
delivery. The persistent non-reassuring (NR) group
comprised fetuses with non-reactive FHR and usually
decreased baseline variability at admission for labor
that persisted until delivery. The reactive-prolonged
deceleration (PD) group comprised fetuses with a nor-
mal FHR pattern at admission for labor and acute
severe prolonged deceleration or bradycardia before
delivery. The Hon pattern group comprised fetuses
with a normal FHR pattern at admission for labor.
Consequently, recurrent severe decelerations with
baseline heart rate increased and baseline variability
decreased. Finally, terminal prolonged deceleration or
bradycardia occurred before delivery. The persistent
reactive group comprised fetuses with a normal FHR
range during the entire course.
Cerebral palsy was deﬁned as a disturbance in
motor function or posture in neonates that was per-
manent or variable. This disorder is based on a non-
progressive cerebral lesion that develops between
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conception and the neonatal period (within 4 weeks
after birth). However, this deﬁnition excludes motor
retardation that is either transient or normalizes in the
future.
The deﬁnition and classiﬁcation of HDP used in
this study followed the guidelines published by the
Japan Society for the Study of Hypertension in
Pregnancy for Japanese obstetric care providers.6
HDP was deﬁned as hypertension (blood pressure
≥ 140/90 mmHg) with or without proteinuria (0.3 g
in a 24 h urine specimen or a protein-to-creatinine
ratio of > 0.30) emerging after 20 weeks of gestation
and resolving up to 12 weeks post-partum. Mild
HDP was diagnosed when blood pressure was
≥ 140/90 mmHg, but < 160/110 mmHg after 20 weeks’
gestation, and proteinuria was ≥ 300 mg/24 h without
exceeding 2.0 g/24 h or 3+ dipstick test results were
observed. Severe HDP was diagnosed when blood
pressure was ≥ 160/110 mmHg and proteinuria
exceeded 2.0 g/24 h or a 3+ dipstick test results were
observed. HDP that emerged earlier than 32 weeks’
gestation was referred to as early-onset and HDP that
emerged after 32 weeks’ gestation was referred to as
late-onset.
Light-for-gestational age infants were diagnosed as
weighing lower than the 10th percentile based on the
standard of Japanese birth for the gestational period.
Statistical analysis
A two-sided P value of 0.05 was used to deﬁne statis-
tical signiﬁcance. All analyses were conducted using
STATA version 13.0. Continuous variables are reported
as mean  standard deviation and were compared
using Student’s t or Mann–Whitney U tests. Integer
variables are reported as median and range, and were
compared using the Mann–Whitney U test. Categori-
cal variables are reported as frequencies and were
compared using Fisher’s exact test.
Table 1 Characteristics of the subjects
Characteristic With HDP
(n = 33)
Without HDP
(n = 450)
P
Maternal characteristics
Age 33.2  5.4 31.1  5.2 0.025
Height (cm) 156.4  5.5 157.9  5.6 0.119
Weight at beginning of pregnancy (kg) 56.2  7.4 53.9  10.5 0.214
BMI (kg/m2) 23.1  3.1 21.6  4.2 0.055
Weight at delivery (kg) 66.0  8.1 64.0  10.1 0.267
Weight gain (kg) 9.6  4.6 10.1  4.1 0.463
Parity (median, range) 00 (0–4) 00 (0–5) 0.895
In vitro fertilization 6.1% (2) 3.6% (16) 0.352
Mode of delivery
Normal spontaneous 15.2% (5) 28.2% (127) 0.204
Instrumental 12.1% (4) 16.2% (73)
Elective CS 3.0% (1) 2.0% (9)
Emergency CS 69.7% (23) 53.6% (241)
Delivery at
Hospital 90.9% (30) 64.4% (290) 0.008
Small hospital with < 20 beds 9.1% (3) 34.7% (156)
Midwifery home 0.0% (0) 0.9% (4)
Maternal transport after onset of labor 18.2% (6) 8.7% (39) 0.110
Neonate
Multiple pregnancy 6.1% (2) 4.2% (19) 0.647
Gestational weeks 37.4  2.1 38.3  1.9 0.011
Birth weight (g) 2582  372 2889  453 < 0.001
Birth weight (SD) −0.7  0.7 −0.1  1.1 0.005
Male 36.4% (12) 53.6% (241) 0.070
Apgar score 1 min (median, range) 1 (0–8) 2 (0–10) 0.017
Apgar score 5 min (median, range) 3 (0–8) 4 (0–10) 0.016
Umbilical artery PH 6.844  0.235 6.990  0.269 0.015
BMI, body mass index; CS, cesarean section; HDP, hypertensive disorder of pregnancy; SD, standard deviation.
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Results
Four hundred and eighty-three cases of CP from the
JOCSC database were included in the study. Thirty-
three neonates with CP born from pregnant women
complicated by HDP during pregnancy and 450 neo-
nates born from pregnant women without HDP were
compared. The characteristics of these subjects are
shown in Table 1. Neonates born to mothers with
HDP were smaller and of an earlier gestational age.
The major relevant obstetric factors for CP
reviewed by the JOCSC in pregnant women with and
without HDP are shown in Table 2. The rate of light-
for-gestational age was signiﬁcantly higher in children
born to mothers with HDP than in those born to
mothers without HDP (P = 0.011). Placental abruption
was signiﬁcantly in higher in children born to
mothers with HDP than in those born to mothers
without HDP (P < 0.001).
A summary of 16 neonates with CP after placental
abruption in mothers with HDP is shown in Table 3.
There were no light-for-gestational age infants. Severe
HDP at the onset of placental abruption was observed
in three (19%) women. Transfer of the mother and
newborn to intensive care was required after the
occurrence of placental abruption in four women
because treatment was difﬁcult in the clinic. In FHR
pattern analysis, bradycardia was observed on
Table 2 Major relevant obstetric factors for cerebral palsy reviewed by the Operating Organization of the JOCSC in neo-
nates and mothers with and without HDP
Major relevant obstetric factors for cerebral palsy With HDP
(n = 33)
Without HDP
(n = 450)
P
Light for gestational age 4 12.1% 10 2.2% 0.011
Placental abnormalities 17 51.5% 115 25.6% 0.002
Placental abruption 16 48.5% 90 20.0% < 0.001
Placental abruption (15) (86)
Placental abruption and cord abnormality (0) (3)
Placental abruption with uterine rupture (0) (1)
Maternal shock after placental abruption (1) (0)
Bleeding of placenta previa 0 0.0% 2 0.4% 1.000
Feto-maternal blood transfusion 0 0.0% 14 3.1% 0.613
Monochorionic-diamniotic twins 1 3.0% 9 2.0% 0.511
Umbilical cord abnormalities 2 6.1% 111 24.7% 0.011
Umbilical cord prolapse 1 3.0% 20 4.4%
Umbilical cord prolapse with cord abnormality 0 0.0% 1 0.2%
Cord abnormalities 1 3.0% 77 17.1%
Cord abnormalities and infectious disease 0 0.0% 12 2.7%
Cord abnormalities and IVH in neonate 0 0.0% 1 0.2%
Maternal complications 2 6.1% 47 10.4% 0.561
Uterine rupture 0 0.0% 17 3.8%
Infectious disease 0 0.0% 22 4.9%
Maternal cardiopulmonary arrest 0 0.0% 2 0.4%
Amniotic ﬂuid embolism 0 0.0% 3 0.7%
Eclampsia 2 6.1% 0 0.0%
Gestational diabetes mellitus 0 0.0% 2 0.4%
Diabetes mellitus 0 0.0% 1 0.2%
Neonatal complications 0 0.0% 10 2.2% 1.000
Blood type incompatibility 0 0.0% 1 0.2%
IVH 0 0.0% 3 0.7%
Cerebral infarct 0 0.0% 2 0.4%
Hypoglycemia 0 0.0% 1 0.2%
Tension pneumothorax 0 0.0% 1 0.2%
Ventricular tachycardia 0 0.0% 1 0.2%
Persistent pulmonary hypertension of the newborn 0 0.0% 1 0.2%
Other causes or unexplained 8 24.2% 157 34.9% 0.256
Umbilical cord abnormalities included velamentous or marginal cord insertion, hypercoiled cord, cord entanglement, a true knot, a single
umbilical artery and umbilical cord constriction. Events associated with intervention during labor included vacuum extraction, forceps
delivery, induction of labor and uterine fundal pressure. HDP, hypertensive disorder in pregnancy; IVH, intraventricular hemorrhage;
JOCSC, Japan Obstetric Compensation System for Cerebral Palsy.
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admission to hospital in 94% (15/16) of fetuses. Most
women with placental abruption underwent immedi-
ate emergency cesarean section. Only one woman had
an umbilical artery pH of > 7.0.
A summary of 11 cases of CP without placental
abruption in mothers with HDP is shown in Table 4.
Five of these 11 (45%) neonates were light-for-
gestational age. FHR pattern analysis showed that the
reassuring pattern was noted on admission, including
reactive-PD, Hon pattern and persisting reassuring in
64% (7/11) of fetuses. However, they were considered
to have suffered asphyxia during labor, resulting in
CP, because prolonged deceleration or the Hon pattern
of FHR was observed before delivery, except in cases
of monochorionic diamniotic twins. The reactive-PD
group was associated with umbilical cord prolapse,
vasa previa, light-for-gestational age and eclampsia.
Discussion
In our study, neonates with CP who weighed
≥ 2000 g at birth after at least 33 weeks’ gestation
were more frequently terminated because of light-for-
gestational age and placental abruption in women
who suffered from HDP than in women without
HDP. Furthermore, FHR pattern analysis showed bra-
dycardia suspected long before admission may lead
to CP from placental abruption in mothers of HDP.
On the other hand, in women without placental
abruption, the FHR pattern was likely to indicate a
favorable fetal condition on admission, but FHR
became worse, such as loss of baseline variability, late
decelerations and prolonged decelerations, with the
progression of labor.
Impaired placentation, placental insufﬁciency, intra-
uterine hypoxia and uteroplacental underperfusion
are considered important mechanisms causing placen-
tal abruption. 7–10 In our study, infants of CP had
been induced hypoxic condition because of persistent
bradycardia in association with placental abruption in
women with HDP. In fact, some pregnant women
with HDP required maternal transport to a higher-
grade hospital to receive intensive care because of the
occurrence of placental abruption.
Even if placental abruption does not occur, because
it is thought that conditions including HDP and fetal
growth restriction associated with ischemic placental
disease can originate during the ﬁrst trimester, these
may be linked through a uniﬁed pathophysiological
mechanism. 11,12 Contrary to CP with placental
abruption in HDP, newborns with CP delivered by
mothers with HDP without placental abruption were
likely to be light-for-gestational age and were associ-
ated with a persistent non-reassuring pattern on
admission. In women without placental abruption,
bradycardia and non-reassuring fetal status at deliv-
ery were observed with the progression of labor in
association with CP, while FHR pattern indicated a
reassuring condition on admission. Such unfavorable
conditions of hypoxia might have been induced by
uteroplacental underperfusion with reduced placental
function as a result of HDP and uterine contractions.
Our results suggest that if a pregnant woman with
HDP is at a hospital in which emergency cesarean
section is not available, the patient should be immedi-
ately transferred to a tertiary hospital, even those with
mild HDP. This will enable preparation of an acute
delivery when progression to crucial conditions
occurs, such as placental abruption or eclampsia.
Additionally, caregivers in delivery services should
perform FHR monitoring strictly in mothers with
HDP because FHR is likely to worsen with the pro-
gression of labor, especially in growth-restricted
fetuses in women with HDP. Daily improvement of
obstetric systems in hospitals, including suitable staff-
ing and education and training for obstetric emer-
gency personnel in HDP, is also required.
Whether acute delivery can prevent CP after the
occurrence of fetal growth restriction and placental
abruption occurring in pregnant women with HDP is
unclear. HDP is considered to be related to chronic
uteroplacental underperfusion with its origin in the
ﬁrst trimester.11,12 Therefore, in some cases of HDP,
antepartum CP might already be present when placen-
tal abruption occurs. In fact, a persistent NR pattern on
admission was observed in our case series with HDP.
Although fetal and neonatal death was not evalu-
ated in the present study, intensive care, even in cases
of mild HDP, and preparation of immediate delivery
will reduce the mortality rate associated with HDP.
However, it is unclear whether the incidence of CP
can be reduced. Furthermore, no fetal growth restric-
tion was observed in women complicated with HDP
and placental abruption in our study. This is because
newborns with CP who were enrolled in the JOCSC
weighed ≥ 2000 g after at least 33 weeks’ gestation. It
is thought that newborns with CP were more fre-
quently observed when delivered by mothers suffer-
ing severe HDP during earlier gestation. Further
research on the management of severe fetal growth
restriction and earlier HDP onset are needed.
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Cerebral palsy and HDP
In conclusion, this large nationwide study shows that
relevant obstetric factors for CP after 33 weeks’ gesta-
tion in association with HDP are light-for-gestational
age and placental abruption. This is the ﬁrst study to
clinically demonstrate FHR patterns in CP cases in
association with HDP. Most newborns with CP whose
mothers suffer placental abruption already have fetal
bradycardia when the mother is admitted to hospital.
In cases without placental abruption, newborns were
likely to be light-for-gestational age and FHR pattern
was associated with a persistent non-reassuring pattern
on admission. Even in cases of a favorable FHR pattern
on admission, FHR is likely to become worse with the
progression of labor. Therefore, although detection of
antepartum CP is impossible, pregnant women with
HDP should be placed under strict observation, includ-
ing maternal and fetal monitoring, to minimize fetal
hypoxic conditions during labor.
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